Importance of antigen specific immunoglobulin responses in controlling SIV/SHIV i

抗原特异性免疫球蛋白反应在控制 SIV/SHIV 中的重要性 i

• 批准号: 7929535
• 负责人: Bapi Pahar
• 金额: $ 24.75万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-12 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7929535
• 关键词: Acquired Immunodeficiency Syndrome; Alveolar; Animals; Antibodies; Antigens; B-Cell Activation; B-Lymphocyte Epitopes; B-Lymphocytes; Bathing; Binding; Bone Marrow; CD4 Positive T Lymphocytes; CD8B1 gene; Couples; Cytotoxic T-Lymphocytes; Disease Progression; Dissociation; Dose; HIV; HIV-1; Helper-Inducer T-Lymphocyte; Heterosexuals; Hypergammaglobulinemia; IgE; Immune; Immune response; Immune system; Immunity; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulin-Secreting Cells; Immunoglobulins; Immunology; Impairment; Individual; Infection; Infection Control; Intestines; Invaded; Irrigation; Kinetics; Lymph Node Tissue; Lymphocyte Function; Macaca; Maintenance; Memory B-Lymphocyte; Modeling; Monkeys; Mucosal Immune Responses; Opportunistic Infections; Pathway interactions; Patients; Peripheral; Plasma; Play; Population; Predisposition; Proliferating; Property; Recombinants; Regulation; Reporting; Role; Route; SIV; SIV Vaccines; Sampling; Secretory Immunoglobulin A; Serum; Site; Small Intestines; Specificity; Surface; Surface Immunoglobulins; Surface Plasmon Resonance; T-Lymphocyte; Technology; Tissues; Vaccines; Viral; Viral Load result; Viremia; Virus; Virus Diseases; antigen antibody binding; arm; combat; design; env Gene Products; exhaustion; lymph nodes; neutralizing antibody; pathogen; peripheral blood; prevent; public health relevance; response; vaccine candidate

DESCRIPTION (provided by applicant): Studies of virus specific immune responses in HIV exposed and infected individuals as well as SIV vaccine studies in monkeys suggest that it is unlikely that vaccine approaches that stimulate a single arm of the immune system will provide effective protection from viral infection. Several studies have shown that strong CD8+ cytotoxic T lymphocytes (CTL) responses may be elicited by infection or vaccine candidates, which may correlate with marginal decreases in viral loads, yet these do not correlate with protection from infection or disease progression. However, In addition to CTL, B-lymphocytes also play an important role in the immune response to infection by secreting neutralizing and non-neutralizing antibodies to combat invading pathogens. There is evidence that HIV-1 impairs protective immunoglobulin G (IgG) and immunoglobulin A (IgA) responses against pathogens and vaccines by inducing progressive loss of these CD4+ T helper cells. The presence of low levels of memory B cells and defective naive B cells in HIV infected patients have also been reported. In summary, B cell dysregulation is likely to play a major role in the progression to AIDS in HIV-infected patients. If so, this in turn suggests that maintenance of normal humoral immune responses may be the key to preventing and controlling infection. HIV-specific mucosal IgA and systemic cellular responses in HIV protection have both been proposed to play a role in studies of discordant heterosexual couples. In addition, several new findings suggest SIV-specific IgA responses in mucosal and peripheral immune compartments are important in controlling viral infection. Recent reports have also shown that the specificity and quantitative properties of antibody binding to antigen plays an important role in determining the neutralizing activity of the antibody. Thus we hypothesize that differences in the quality of antigen specific immunoglobulin (Ig) responses will be observed in animals in which viral loads are reduced or undetectable compared to animals that have persistent viremia and progress to AIDS. We also hypothesize that the level of antigen-antibody binding properties and antigen-specific effector memory B cells in tissues or secretory Ig will correlate with the reduction of viral load or disease progression in SIV infected macaques. In the proposed studies, we will examine and compare SIV-specific IgA, IgG and IgM immune responses and antibody binding properties in peripheral blood, and mucosal secretions of macaques inoculated with SIVmac251 and/or SHIVsf162p3. We will also examine the effector function of memory B cells in peripheral blood, broncho-alveolar lavage (BAL), bone marrow (BM), small intestine and lymph node tissues from SIV infected macaques. The specific aims are: Specific Aim 1: To compare the role of antigen specific IgA, IgG and IgM immune responses in macaques with different levels of immunity to SIV/SHIV infection. We will compare antigen specific IgA, IgG and IgM responses in macaques intravenously, intravaginally, and intrarectally inoculated with SIVmac251 (a highly pathogenic virus that consistently results in persistent viremia and AIDS). Antigen specific immunoglobulin responses will also be assessed in SIVmac251 and SHIVsf162p3 inoculated macaques which are able to control their infection and become long-term nonprogressors (LTNP). We will also be able to identify major IgA, IgG and IgM specific B cell epitopes and their role in differentiating the immune responses of SIV inoculated protected and unprotected macaques. Specific Aim 2: To determine the kinetics of antibody binding properties in macaques with different levels of immunity to SIV/SHIV infection. We will also compare quantitative and qualitative binding properties of all longitudinal plasma/serum samples and/or mucosal secretions from macaques with different levels of immunity to trimeric recombinant SIV/SHIVgp140 envelope proteins using surface plasmon resonance (SPR) technology (Biacore). We expect that a difference in the quality of antibody population might exist in macaques which are able to control viremia compared to those that rapidly progress to AIDS. Specific Aim 3: To quantify effector memory B cells in macaques infected with SIV by different routes of inoculation. We hypothesize that mucosal immune responses may differ depending on the route of inoculation. Thus, effector memory B cells will be evaluated and quantified in different tissues including peripheral blood, intestines, lymph nodes, BM, and BAL samples of intravenously and mucosally inoculated macaques. We will also quantify secretory IgA and IgG from both systemic and mucosal immune sites. Using this approach, we predict that we will be able to correlate SIV specific mucosal immune responses with reduction of viremia and protection from disease progression in macaques infected with pathogenic viruses. PUBLIC HEALTH RELEVANCE: Studies of virus specific immune responses in HIV exposed and infected individuals as well as SIV vaccine studies in monkeys suggest that it is unlikely that vaccine approaches that stimulate a single arm of the immune system will provide effective protection from viral infection. Several studies have shown that strong CD8+ cytotoxic T lymphocytes (CTL) responses may be elicited by infection or vaccine candidates, which may correlate with marginal decreases in viral loads, yet these do not correlate with protection from infection or disease progression. However, In addition to CTL, B-lymphocytes also play an important role in the immune response to infection by secreting neutralizing and non-neutralizing antibodies to combat invading pathogens. B cell dysregulation is likely to play a major role in the progression to AIDS in HIV-infected patients. If so, this in turn suggests that maintenance of normal humoral immune responses may be the key to preventing and controlling infection. Thus we hypothesize that differences in the quality of antigen specific immunoglobulin (Ig) responses will be observed in animals in which viral loads are reduced or undetectable compared to animals that have persistent viremia and progress to AIDS. We also hypothesize that the level of antigen-antibody binding properties and antigen-specific effector memory B cells in tissues or secretory Ig will correlate with the reduction of viral load or disease progression in SIV infected macaques. In the proposed studies, we will examine and compare SIV-specific IgA, IgG and IgM immune responses and antibody binding properties in peripheral blood, and mucosal secretions of macaques inoculated with SIVmac251 and/or SHIVsf162p3. We will also examine the effector function of memory B cells in peripheral blood, broncho-alveolar lavage (BAL), bone marrow (BM), small intestine and lymph node tissues from SIV infected macaques. Using this approach, we predict that we will be able to correlate SIV specific mucosal immune responses with reduction of viremia and protection from disease progression in macaques infected with pathogenic viruses.

描述（由申请人提供）：对HIV暴露和感染个体的病毒特异性免疫反应的研究以及对猴子的SIV疫苗研究表明，刺激免疫系统单臂的疫苗方法不太可能提供有效的病毒感染保护。几项研究表明，感染或候选疫苗可能引发强烈的CD8+细胞毒性T淋巴细胞（CTL）反应，这可能与病毒载量的边际下降有关，但这些与免受感染或疾病进展的保护无关。然而，除了CTL， b淋巴细胞还通过分泌中和和非中和抗体来对抗入侵的病原体，在感染的免疫反应中发挥重要作用。有证据表明，HIV-1通过诱导这些CD4+ T辅助细胞的逐渐丧失，损害了针对病原体和疫苗的保护性免疫球蛋白G （IgG）和免疫球蛋白A （IgA）反应。HIV感染患者中存在低水平的记忆B细胞和有缺陷的初始B细胞。总之，B细胞失调可能在hiv感染患者发展为艾滋病的过程中发挥重要作用。如果是这样，这反过来表明维持正常的体液免疫反应可能是预防和控制感染的关键。HIV特异性粘膜IgA和全身细胞反应在HIV保护中都被提出在不和谐异性恋夫妇的研究中发挥作用。此外，一些新的研究结果表明，粘膜和外周免疫室中siv特异性IgA反应对控制病毒感染很重要。最近的报道也表明，抗体与抗原结合的特异性和定量性质在决定抗体的中和活性方面起着重要作用。因此，我们假设，在病毒载量减少或检测不到的动物中，与持续病毒血症并进展为艾滋病的动物相比，抗原特异性免疫球蛋白（Ig）反应的质量将有所不同。我们还假设，在SIV感染的猕猴中，抗原抗体结合特性和组织中抗原特异性效应记忆B细胞的水平或分泌Ig将与病毒载量的减少或疾病进展相关。在拟开展的研究中，我们将检测和比较接种SIVmac251和/或SHIVsf162p3的猕猴外周血和粘膜分泌物中siv特异性IgA、IgG和IgM免疫反应和抗体结合特性。我们还将研究记忆B细胞在SIV感染猕猴外周血、支气管肺泡灌洗液（BAL）、骨髓（BM）、小肠和淋巴结组织中的效应功能。具体目标是：